Test Module 2

The World Health Organization’s first global report on sepsis finds that the effort to tackle millions of deaths and disabilities due to sepsis is hampered by serious gaps in knowledge, particularly in low- and middle-income countries. According to recent studies, sepsis kills 11 million people each year, many of them children. It disables millions more.

But there’s an urgent ne

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Global Health, Global Women's Issues

This letter will focus largely on WHO’s efforts to address the double challenge of malaria & COVID-19. Our work in recent months has been carried out in close collaboration with country-based experts and global partners. We are very grateful to all of our partners for their ongoing commitment and contributions.

Roles: Everyone: All Users

Regions: Chad , China, France , Italy , Rwanda , Sierra Leone , United Kingdom

Topics: Coronavirus (COVID-19), Global Health

Pregnant women with COVID-19 are less likely than non-pregnant women with COVID-19 to have symptoms, but more likely to need intensive care if severely ill – according to new findings

New research findings published today in the BMJ help to shed light on the risks of COVID-19 for pregnant women and their babies. The paper suggests that pregnant women seen at the hospital with suspected or confirmed COVID-19 are less likely to

Roles: Everyone: All Users

Regions: United Kingdom

Topics: Coronavirus (COVID-19), Global Health

Togo has received validation from the World Health Organization (WHO) for having eliminated human African trypanosomiasis or “sleeping sickness” as a public health problem, becoming the first country in Africa to reach this milestone.

Roles: Everyone: All Users

Regions: Ghana , Togo , United Kingdom

Topics: Global Health

WHO to roll out learning and monitoring tools to improve service provision during pandemic

The World Health Organization (WHO) today published a first indicative survey on the impact of COVID-19 on health systems based on 105 countries’ reports. Data collected from five regions over the period from March to June 2020 illustrate that almost every country (90%) experi

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Global Health

Information Exchange System

Roles: Everyone: All Users

Topics: Global Women's Issues

Scope (COVID-19 and non-COVID-19 patients affected by the pandemic)

The International Narcotics Control Board (INCB), the World Health Organization (WHO) and the United Nations Office on Drugs and Crime (UNODC) call on governments to ensure that the procurement and supply of controlled medicines in countries meet the needs of patients, both those who have COVID-19 and those who require internationally controlled medicines for other medical conditions.

There is a need to ensure access t

Roles: Everyone: All Users

Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Global Health

Countries implementing control programmes to treat people infected with or at risk of epilepsy-associated tapeworm infection can now benefit from medicines donated to WHO. Under a five-year agreement, the German pharmaceutical company, Bayer, has agreed to donate 2.8 million tablets of niclosamide and 1.5 million tablets of praziquantel to WHO for distribution to affected countries. To benefit from this donation, a few steps and forms need to be completed.

Roles: Everyone: All Users

Topics: Energy, Global Health

Meaningful youth engagement to improve adolescent sexual and reproductive health and rights  

Every day, young people are enriching institutions and processes at the local, national, and global levels.  

This year, the theme of International Youth Day is "Youth Engagement for Global Action

Roles: Everyone: All Users

Date: 7 August 2020

Subject: Substandard/Falsified medical devices and personal protective equipment (PPE) used in the context of the COVID-19 pandemic

WHO-identifier: 2020/3, version 1

Type of action: Advice to users of medical devices and PPE used for prevention, treatment and care for COVID-19.<

Roles: Everyone: All Users

Regions: United Kingdom

Topics: Climate and Environment, Coronavirus (COVID-19), Energy, Global Health

The second edition provides an improved basis for policy debate and informed decision-making at a critical time for global health.

Roles: Everyone: All Users

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

During the second quarter of 2020, the INFOSAN Secretariat has been involved in 29 food safety incidents with 59 WHO Member States and two territories of WHO Member States. There were 13 biological hazard incidents (Salmonella [5], Listeria monocytogenes [3], Clostridium botulinum [2], Vibrio cholerae [1], and two involving an unspecified biological hazard), six with a chemical hazard (methanol [3], histamine [2] and patulin [1]), five involving an undeclared allergen (cashew and pistachio [1], sesame [1],

Roles: Everyone: All Users

Regions: Australia , Cambodia , Canada , China, Dominican Republic , France , Hong Kong , Mexico , Singapore , United States

Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Energy, Global Health

Schoolboy Yangyang was growing weaker by the day. When his symptoms worsened into diarrhoea and abdominal pain, his parents took him to the nearest hospital in Guangxi, southeastern China, where the doctor examined him on arrival and administered treatment. To confirm his suspicion, the doctor ordered a fecal examination. The result confirmed that Yangyang was suffering from a parasitic infection of the liver that can be caused by eating raw fish – a traditional dietary practice that has developed into a gr

Roles: Everyone: All Users

Regions: China, United Kingdom

Topics: Energy, Global Health, Science, Technology, and Innovation

Snakebite envenoming is a common problem in many parts of the world, but little is known about its magnitude in the Arab countries of the Middle East, where cases are not widely reported. The aim is to halve the numbers of deaths and cases of disability due to snakebite envenoming over the next 12 years through a programme that targets affected communities and their health systems, and by ensuring access to safe, effective treatment through increased cooperation, collaboration and partnership at all leve

Roles: Everyone: All Users

Regions: Jordan , Kuwait , Syria , United Kingdom , Yemen

Topics: Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

Launching today, the COVID-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the pandemic. The goal is to ensure that laws protect the health and wellbeing of individuals and communities and that they adhere to international human rights standards.

The new Lab (at www.COVIDLawLab.org) is a joint project of United Nations D

Roles: Everyone: All Users

Regions: United Kingdom

Topics: Climate and Environment, Combating Drugs and Crime, Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

Eleven New Psychoactive Substances to be considered for international control by 43rd ECDD

Roles: Everyone: All Users

Topics: Combating Drugs and Crime

A software application has been developed to make it easier for healthcare workers and the public to get instant, real-time information on the estimated ten neglected tropical diseases of the skin (also known as SkinNTDs).

Roles: Everyone: All Users

Regions: France

Topics: Global Health, Science, Technology, and Innovation

A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.

Roles: Everyone: All Users

Regions: United Kingdom

Topics: Global Health, Science, Technology, and Innovation

Good-quality medicines, given at the right time, can save the lives of pregnant and recently pregnant women and their newborn babies. New evidence synthesis reveals however, that in many health-care settings across the world, women with life-threatening maternal complications are given poor quality medicines – putting their lives and well-being at grave risk.

The systematic review, authored by staff at WHO Department of Sexual and Reproductive Health and Research

Roles: Everyone: All Users

Topics: Combating Drugs and Crime, Global Women's Issues

GENEVA — A new Access Initiative for Quitting Tobacco aims to help the world's 1.3 billion tobacco users quit. Stopping smoking is more important than ever as evidence reveals that smokers are more likely than non-smokers to have severe outcomes from COVID-19.

The project gives people free access to nicotine replacement therapy and to Florence, a digital health worker, based on artificial intelligence that dispels myths around COVID-19 and tobacco and helps people develop a personalized plan

Roles: Everyone: All Users

Regions: Jordan , New Zealand

Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

Today, more than 20 leading biopharmaceutical companies are announcing the launch of the AMR Action Fund that will invest in developing innovative antibacterial treatments. The Fund aims to bring 2-4 new treatments to patients by 2030. This initiative is a significant step towards addressing the current crisis in antibacterial treatment development.

World Chagas Disease Day: bringing a forgotten disease to the fore of global attention